Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 8 | 2025 | 449 | 1.570 |
Why?
|
| Drug Design | 2 | 2024 | 183 | 1.530 |
Why?
|
| Suicide | 3 | 2022 | 139 | 1.520 |
Why?
|
| Metal Nanoparticles | 5 | 2025 | 227 | 1.520 |
Why?
|
| Ferric Compounds | 3 | 2025 | 62 | 1.120 |
Why?
|
| Palladium | 3 | 2025 | 30 | 1.110 |
Why?
|
| Biocompatible Materials | 3 | 2025 | 106 | 1.010 |
Why?
|
| Alginates | 3 | 2024 | 19 | 0.980 |
Why?
|
| Contrast Media | 1 | 2025 | 101 | 0.880 |
Why?
|
| Carbon | 6 | 2025 | 127 | 0.880 |
Why?
|
| Zirconium | 1 | 2024 | 11 | 0.870 |
Why?
|
| Biological Availability | 1 | 2024 | 115 | 0.870 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 60 | 0.860 |
Why?
|
| Silicon Dioxide | 2 | 2022 | 38 | 0.840 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 246 | 0.830 |
Why?
|
| Nanofibers | 1 | 2023 | 14 | 0.830 |
Why?
|
| Sulfamethoxazole | 1 | 2023 | 1 | 0.800 |
Why?
|
| Quantum Dots | 4 | 2025 | 38 | 0.800 |
Why?
|
| Proteins | 2 | 2023 | 383 | 0.790 |
Why?
|
| Copper | 3 | 2024 | 134 | 0.770 |
Why?
|
| Graphite | 2 | 2023 | 61 | 0.760 |
Why?
|
| Plastics | 1 | 2022 | 13 | 0.760 |
Why?
|
| Hot Temperature | 2 | 2022 | 141 | 0.750 |
Why?
|
| Antineoplastic Agents | 4 | 2025 | 979 | 0.740 |
Why?
|
| Biomass | 2 | 2020 | 66 | 0.730 |
Why?
|
| Charcoal | 1 | 2020 | 6 | 0.680 |
Why?
|
| Lignin | 4 | 2021 | 8 | 0.670 |
Why?
|
| Sewage | 1 | 2020 | 27 | 0.670 |
Why?
|
| Nanotechnology | 2 | 2024 | 176 | 0.610 |
Why?
|
| Porosity | 5 | 2025 | 42 | 0.590 |
Why?
|
| Corchorus | 1 | 2018 | 2 | 0.580 |
Why?
|
| Oxygen | 3 | 2024 | 217 | 0.580 |
Why?
|
| Acids | 1 | 2018 | 19 | 0.570 |
Why?
|
| Biosensing Techniques | 2 | 2019 | 130 | 0.560 |
Why?
|
| Glucose | 2 | 2022 | 242 | 0.550 |
Why?
|
| Search Engine | 1 | 2017 | 7 | 0.550 |
Why?
|
| Curcumin | 1 | 2018 | 115 | 0.520 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 518 | 0.520 |
Why?
|
| DNA | 1 | 2019 | 594 | 0.490 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 457 | 0.490 |
Why?
|
| Colonic Neoplasms | 2 | 2022 | 223 | 0.480 |
Why?
|
| Internet | 1 | 2017 | 234 | 0.480 |
Why?
|
| Ferrocyanides | 1 | 2015 | 3 | 0.470 |
Why?
|
| Cell Survival | 6 | 2025 | 934 | 0.470 |
Why?
|
| Durapatite | 1 | 2015 | 18 | 0.470 |
Why?
|
| Microspheres | 1 | 2015 | 49 | 0.460 |
Why?
|
| Divorce | 1 | 2014 | 7 | 0.460 |
Why?
|
| Drug Delivery Systems | 5 | 2024 | 273 | 0.460 |
Why?
|
| Fever | 1 | 2015 | 63 | 0.450 |
Why?
|
| Cellulose | 3 | 2023 | 23 | 0.450 |
Why?
|
| Hepatocytes | 1 | 2015 | 79 | 0.450 |
Why?
|
| Humans | 25 | 2025 | 42163 | 0.450 |
Why?
|
| Cisplatin | 1 | 2015 | 91 | 0.450 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 84 | 0.430 |
Why?
|
| Cultural Characteristics | 1 | 2014 | 128 | 0.430 |
Why?
|
| Drug Carriers | 1 | 2015 | 169 | 0.420 |
Why?
|
| Taiwan | 4 | 2023 | 21 | 0.400 |
Why?
|
| Catalysis | 6 | 2024 | 191 | 0.390 |
Why?
|
| Galectin 3 | 1 | 2012 | 29 | 0.390 |
Why?
|
| Animals | 14 | 2025 | 16695 | 0.380 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 68 | 0.370 |
Why?
|
| Particle Size | 5 | 2024 | 267 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 415 | 0.350 |
Why?
|
| Iron | 2 | 2024 | 247 | 0.350 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1679 | 0.340 |
Why?
|
| Platinum | 3 | 2022 | 23 | 0.340 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 189 | 0.340 |
Why?
|
| Photolysis | 2 | 2024 | 25 | 0.340 |
Why?
|
| Mice | 8 | 2025 | 6490 | 0.330 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 2598 | 0.300 |
Why?
|
| Water Pollutants, Chemical | 2 | 2024 | 170 | 0.280 |
Why?
|
| Surface Properties | 3 | 2024 | 157 | 0.270 |
Why?
|
| Fluorescent Dyes | 2 | 2025 | 182 | 0.260 |
Why?
|
| Zeolites | 2 | 2017 | 9 | 0.260 |
Why?
|
| Solvents | 2 | 2024 | 109 | 0.250 |
Why?
|
| Polymers | 3 | 2022 | 151 | 0.250 |
Why?
|
| Coloring Agents | 2 | 2023 | 56 | 0.250 |
Why?
|
| Imidazoles | 2 | 2017 | 138 | 0.240 |
Why?
|
| Mice, Nude | 2 | 2025 | 403 | 0.240 |
Why?
|
| Hexuronic Acids | 2 | 2015 | 8 | 0.240 |
Why?
|
| Glucuronic Acid | 2 | 2015 | 8 | 0.240 |
Why?
|
| Osteoarthritis | 1 | 2025 | 25 | 0.230 |
Why?
|
| Organosilicon Compounds | 1 | 2025 | 4 | 0.230 |
Why?
|
| Hep G2 Cells | 2 | 2015 | 62 | 0.230 |
Why?
|
| Tomography, X-Ray | 1 | 2024 | 1 | 0.220 |
Why?
|
| Hafnium | 1 | 2024 | 2 | 0.220 |
Why?
|
| Nanocomposites | 2 | 2022 | 23 | 0.220 |
Why?
|
| Photochemotherapy | 1 | 2024 | 42 | 0.220 |
Why?
|
| Ciprofloxacin | 1 | 2024 | 16 | 0.220 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2024 | 53 | 0.220 |
Why?
|
| Photosensitizing Agents | 1 | 2024 | 55 | 0.210 |
Why?
|
| Hordeum | 1 | 2024 | 15 | 0.210 |
Why?
|
| Temperature | 4 | 2020 | 314 | 0.210 |
Why?
|
| Emulsions | 1 | 2023 | 35 | 0.210 |
Why?
|
| Hepatitis B | 1 | 2023 | 41 | 0.210 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 94 | 0.210 |
Why?
|
| Pharmaceutical Preparations | 1 | 2024 | 93 | 0.200 |
Why?
|
| Congo Red | 1 | 2023 | 4 | 0.200 |
Why?
|
| Peroxides | 1 | 2023 | 21 | 0.200 |
Why?
|
| Crohn Disease | 1 | 2023 | 69 | 0.200 |
Why?
|
| Silver | 1 | 2023 | 61 | 0.200 |
Why?
|
| Hyperthermia, Induced | 1 | 2023 | 27 | 0.200 |
Why?
|
| Staphylococcus aureus | 1 | 2023 | 91 | 0.190 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 60 | 0.190 |
Why?
|
| Colorimetry | 1 | 2022 | 52 | 0.190 |
Why?
|
| Ions | 2 | 2022 | 71 | 0.190 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 101 | 0.190 |
Why?
|
| Vaccines | 1 | 2023 | 64 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 301 | 0.190 |
Why?
|
| Pyrenes | 1 | 2022 | 26 | 0.190 |
Why?
|
| Pyrogallol | 1 | 2021 | 2 | 0.190 |
Why?
|
| Acetophenones | 1 | 2021 | 10 | 0.190 |
Why?
|
| Ligands | 1 | 2023 | 387 | 0.180 |
Why?
|
| Unemployment | 1 | 2022 | 27 | 0.180 |
Why?
|
| Poaceae | 1 | 2021 | 14 | 0.180 |
Why?
|
| Carcinoma | 1 | 2023 | 106 | 0.180 |
Why?
|
| Microwaves | 1 | 2021 | 27 | 0.180 |
Why?
|
| Molecular Structure | 1 | 2023 | 560 | 0.180 |
Why?
|
| Water Purification | 1 | 2021 | 33 | 0.180 |
Why?
|
| Gold | 2 | 2020 | 153 | 0.170 |
Why?
|
| Ketamine | 1 | 2020 | 12 | 0.170 |
Why?
|
| Ecosystem | 1 | 2022 | 171 | 0.170 |
Why?
|
| Criminals | 1 | 2020 | 18 | 0.170 |
Why?
|
| Nanostructures | 1 | 2023 | 158 | 0.170 |
Why?
|
| Female | 8 | 2022 | 24018 | 0.170 |
Why?
|
| Escherichia coli | 1 | 2023 | 461 | 0.170 |
Why?
|
| Models, Molecular | 3 | 2020 | 875 | 0.170 |
Why?
|
| Research | 1 | 2022 | 177 | 0.170 |
Why?
|
| Levulinic Acids | 1 | 2019 | 2 | 0.160 |
Why?
|
| Inflammation | 1 | 2025 | 729 | 0.160 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2022 | 82 | 0.160 |
Why?
|
| Chromium | 1 | 2019 | 29 | 0.150 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 479 | 0.150 |
Why?
|
| Phenols | 2 | 2020 | 102 | 0.150 |
Why?
|
| Mycophenolic Acid | 1 | 2018 | 17 | 0.150 |
Why?
|
| Doxorubicin | 3 | 2025 | 95 | 0.150 |
Why?
|
| Graft Rejection | 1 | 2018 | 43 | 0.150 |
Why?
|
| Graft Survival | 1 | 2018 | 47 | 0.150 |
Why?
|
| Metals | 1 | 2019 | 113 | 0.150 |
Why?
|
| Heart Transplantation | 1 | 2018 | 47 | 0.150 |
Why?
|
| Caco-2 Cells | 2 | 2022 | 59 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2018 | 74 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2018 | 973 | 0.140 |
Why?
|
| Acetylation | 1 | 2018 | 108 | 0.140 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 94 | 0.140 |
Why?
|
| Ionic Liquids | 1 | 2018 | 20 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2018 | 60 | 0.140 |
Why?
|
| RNA | 1 | 2019 | 266 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 164 | 0.130 |
Why?
|
| Smad4 Protein | 1 | 2017 | 8 | 0.130 |
Why?
|
| Dendrimers | 1 | 2016 | 15 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 41 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 339 | 0.130 |
Why?
|
| Catalase | 1 | 2017 | 111 | 0.130 |
Why?
|
| Attitude | 1 | 2017 | 108 | 0.130 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 55 | 0.120 |
Why?
|
| Polyethylene Glycols | 3 | 2023 | 101 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 233 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 1554 | 0.120 |
Why?
|
| Male | 6 | 2024 | 22779 | 0.120 |
Why?
|
| Language | 1 | 2017 | 181 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 506 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 661 | 0.120 |
Why?
|
| Galactosamine | 1 | 2015 | 4 | 0.120 |
Why?
|
| Chemical Precipitation | 1 | 2015 | 9 | 0.120 |
Why?
|
| Thermogravimetry | 1 | 2015 | 7 | 0.120 |
Why?
|
| Urinary Bladder | 1 | 2015 | 30 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2018 | 355 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 214 | 0.120 |
Why?
|
| Magnetics | 1 | 2015 | 43 | 0.120 |
Why?
|
| X-Ray Diffraction | 1 | 2015 | 66 | 0.120 |
Why?
|
| Blood Coagulation | 1 | 2015 | 29 | 0.120 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 158 | 0.110 |
Why?
|
| Endocytosis | 1 | 2015 | 117 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 289 | 0.110 |
Why?
|
| Oxidation-Reduction | 3 | 2021 | 448 | 0.110 |
Why?
|
| Powders | 2 | 2024 | 20 | 0.100 |
Why?
|
| Freeze Drying | 2 | 2024 | 29 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3077 | 0.100 |
Why?
|
| Administration, Intranasal | 2 | 2024 | 89 | 0.100 |
Why?
|
| Hydrogels | 2 | 2024 | 55 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2013 | 12 | 0.100 |
Why?
|
| Gastrointestinal Agents | 2 | 2023 | 6 | 0.100 |
Why?
|
| Remission Induction | 2 | 2023 | 19 | 0.100 |
Why?
|
| Arteriosclerosis | 1 | 2013 | 42 | 0.100 |
Why?
|
| raf Kinases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cell Movement | 2 | 2017 | 640 | 0.100 |
Why?
|
| Dinoprostone | 1 | 2013 | 69 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 577 | 0.100 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 98 | 0.100 |
Why?
|
| Nitrogen | 2 | 2024 | 83 | 0.100 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 129 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2013 | 86 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 68 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 72 | 0.090 |
Why?
|
| ras Proteins | 1 | 2012 | 54 | 0.090 |
Why?
|
| Mice, SCID | 1 | 2012 | 158 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 55 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 188 | 0.090 |
Why?
|
| Hydrogen Peroxide | 2 | 2023 | 193 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2013 | 268 | 0.090 |
Why?
|
| Sex Factors | 1 | 2014 | 1008 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2485 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 228 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 436 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 211 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2022 | 184 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2025 | 1420 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2023 | 1586 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 933 | 0.060 |
Why?
|
| Swine | 2 | 2018 | 205 | 0.060 |
Why?
|
| Child | 2 | 2024 | 3381 | 0.060 |
Why?
|
| Neoplasms | 1 | 2016 | 1341 | 0.060 |
Why?
|
| Dogs | 1 | 2025 | 201 | 0.060 |
Why?
|
| Molybdenum | 1 | 2024 | 18 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2024 | 64 | 0.060 |
Why?
|
| Fibrosis | 1 | 2025 | 166 | 0.060 |
Why?
|
| Electrochemical Techniques | 1 | 2024 | 30 | 0.060 |
Why?
|
| Administration, Cutaneous | 1 | 2024 | 48 | 0.060 |
Why?
|
| Bismuth | 1 | 2024 | 5 | 0.050 |
Why?
|
| Tungsten | 1 | 2024 | 8 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2024 | 70 | 0.050 |
Why?
|
| Edetic Acid | 1 | 2024 | 23 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2024 | 92 | 0.050 |
Why?
|
| Disulfides | 1 | 2024 | 92 | 0.050 |
Why?
|
| Aerosols | 1 | 2024 | 53 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2025 | 278 | 0.050 |
Why?
|
| Minerals | 1 | 2024 | 52 | 0.050 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2024 | 93 | 0.050 |
Why?
|
| Methylene Blue | 1 | 2023 | 7 | 0.050 |
Why?
|
| Cotton Fiber | 1 | 2023 | 5 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2023 | 47 | 0.050 |
Why?
|
| Recurrence | 1 | 2023 | 149 | 0.050 |
Why?
|
| Antigens | 1 | 2023 | 58 | 0.050 |
Why?
|
| Sodium Hydroxide | 1 | 2023 | 4 | 0.050 |
Why?
|
| Tetracycline | 1 | 2023 | 17 | 0.050 |
Why?
|
| Light | 1 | 2024 | 182 | 0.050 |
Why?
|
| Nitrophenols | 1 | 2022 | 5 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 53 | 0.050 |
Why?
|
| Sulfur | 1 | 2022 | 21 | 0.050 |
Why?
|
| Peroxidase | 1 | 2022 | 57 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2023 | 238 | 0.050 |
Why?
|
| Electrodes | 1 | 2022 | 57 | 0.050 |
Why?
|
| Aluminum Oxide | 1 | 2021 | 11 | 0.050 |
Why?
|
| Titanium | 1 | 2022 | 46 | 0.050 |
Why?
|
| Distillation | 1 | 2021 | 3 | 0.050 |
Why?
|
| Electrons | 1 | 2022 | 74 | 0.050 |
Why?
|
| Pyrroles | 1 | 2021 | 68 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 332 | 0.040 |
Why?
|
| Alcohols | 1 | 2020 | 14 | 0.040 |
Why?
|
| Electrochemistry | 1 | 2020 | 38 | 0.040 |
Why?
|
| Micelles | 1 | 2020 | 36 | 0.040 |
Why?
|
| Biofuels | 1 | 2020 | 15 | 0.040 |
Why?
|
| Water | 1 | 2023 | 314 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 157 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 82 | 0.040 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2019 | 4 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 43 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2018 | 9 | 0.040 |
Why?
|
| Acute Disease | 1 | 2018 | 156 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 233 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1054 | 0.030 |
Why?
|
| Phototherapy | 1 | 2016 | 25 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 60 | 0.030 |
Why?
|
| Surface-Active Agents | 1 | 2016 | 44 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2016 | 74 | 0.030 |
Why?
|
| Alloys | 1 | 2016 | 5 | 0.030 |
Why?
|
| Photochemical Processes | 1 | 2016 | 19 | 0.030 |
Why?
|
| Amination | 1 | 2016 | 6 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 420 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2016 | 49 | 0.030 |
Why?
|
| Aldehydes | 1 | 2016 | 69 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 491 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 698 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1848 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1112 | 0.030 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 8 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 37 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2013 | 67 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1617 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 692 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 5950 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1541 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 1131 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 2111 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 13458 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 11819 | 0.020 |
Why?
|